EUVIMEDEUVIMED entdecken
Crossref

Donepezil improves skeletal muscle insulin resistance in obese mice via the AMPK/FGF21-mediated suppression of inflammation and ferroptosis

Hyeon Ji Gwon, Wonjun Cho, Sung Woo Choi, Do Su Lim, Esra Çinar Tanriverdi, A M Abd El-Aty, Ji Hoon Jeong, Tae Woo Jung

Archives of Pharmacal Research · 2024-12 · 47 (12) · 940-953

DOI: 10.1007/s12272-024-01518-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Pharmacal Research, online erschienen am 24.11.2024. Verfasst von Hyeon Ji Gwon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Donepezil, Insulin Resistance, Muscle, Skeletal, Inflammation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National research foundation (KR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Donepezil has traditionally been used in Alzheimer's disease treatment and is known for its ability to alleviate neural inflammation and apoptosis. However, its impact on insulin signaling remains unexplored. This study sought to elucidate the novel role of donepezil in mitigating skeletal muscle insulin resistance under hyperlipidemic conditions. Western blot analysis was used to assess the expression of various proteins of interest, whereas a glucose uptake assay was performed in skeletal muscle cells via commercially available kits. An in vitro model of obesity was developed using palmitate. These in vitro findings were corroborated in vivo via insulin resistance models established through high-fat diet (HFD) feeding in mice. Intraperitoneal glucose tolerance tests and insulin tolerance tests were performed on the experimental mice. The results revealed that donepezil treatment improved insulin signaling and inflammation in palmitate-treated C2C12 myocytes and the skeletal muscle of HFD-fed mice. Notably, donepezil treatment augmented FGF21 expression and AMPK phosphorylation in the myocytes and skeletal muscle of HFD-fed mice. Knockdown of FGF21 or AMPK via siRNA reversed the effects of donepezil on insulin signaling and inflammation in cultured myocytes. We also found that donepezil ameliorated skeletal muscle insulin resistance via the FGF21-mediated suppression of ferroptosis under hyperlipidemic conditions. These findings suggest that donepezil enhances the FGF21/AMPK axis, thereby mitigating inflammation and insulin resistance in skeletal muscle. This study introduces a novel therapeutic approach for treating Alzheimer's disease patients with insulin resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DonepezilInsulin ResistanceMuscle, SkeletalInflammationFibroblast Growth FactorsMice, Inbred C57BLDiet, High-FatAMP-Activated Protein KinasesObesityAnimalsMiceMaleMice, ObeseCells, Cultured

Stichwörter der Autor:innen

AMPKDonepezilFGF21InflammationInsulin resistanceObesity

Substanzen

Donepezilfibroblast growth factor 21Fibroblast Growth FactorsAMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
  • Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, Republic of Korea.
  • Department of Medical Education, Faculty of Medicine, Ataturk University, Erzurum, 25240, Turkey.
  • Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, 12211, Egypt.
  • Department of Medical Pharmacology, Medical Faculty, Ataturk University, Erzurum, 25240, Turkey.
  • Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. twjung@cau.ac.kr.

Förderung

  • National research foundation (KR)

Zitieren

APA

Gwon, H. J., Cho, W., Choi, S. W., Lim, D. S., Tanriverdi, E. Ç., Abd El-Aty, A. M., Jeong, J. H., & Jung, T. W. (2024). Donepezil improves skeletal muscle insulin resistance in obese mice via the AMPK/FGF21-mediated suppression of inflammation and ferroptosis. Archives of Pharmacal Research, 47(12), 940-953. https://doi.org/10.1007/s12272-024-01518-w

Vancouver

Gwon HJ, Cho W, Choi SW, Lim DS, Tanriverdi EÇ, Abd El-Aty AM, et al. Donepezil improves skeletal muscle insulin resistance in obese mice via the AMPK/FGF21-mediated suppression of inflammation and ferroptosis. Archives of Pharmacal Research. 2024;47(12):940-953. doi:10.1007/s12272-024-01518-w

BibTeX
@article{Gwon2024,
  author = {Gwon, Hyeon Ji and Cho, Wonjun and Choi, Sung Woo and Lim, Do Su and Tanriverdi, Esra Çinar and Abd El-Aty, A M and Jeong, Ji Hoon and Jung, Tae Woo},
  title = {Donepezil improves skeletal muscle insulin resistance in obese mice via the AMPK/FGF21-mediated suppression of inflammation and ferroptosis},
  journal = {Archives of Pharmacal Research},
  year = {2024},
  volume = {47},
  number = {12},
  pages = {940--953},
  doi = {10.1007/s12272-024-01518-w}
}
Kostenlos starten →